Karin Jirström
111 – 120 of 349
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Prognostic value of HER3 and HER2 alterations in colorectal cancer: Relationship with sidedness, KRAS and BRAF mutation status
2017) European Society of Medical Oncologys annual congress(
- Contribution to conference › Abstract
-
Mark
Combined and individual tumor-specific expression of insulinlike growth factor-I receptor, insulin receptor and phosphoinsulin- like growth factor-I receptor/insulin receptor in primary breast cancer : Implications for prognosis in different treatment groups
(
- Contribution to journal › Article
-
Mark
The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite : A cohort study
(
- Contribution to journal › Article
-
Mark
The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker
(
- Contribution to journal › Article
-
Mark
Infiltration of γδ T cells, IL-17 + T cells and FoxP3 + T cells in human breast cancer
(
- Contribution to journal › Article
-
Mark
Podocalyxin-like and rna-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer : A validatory study
(
- Contribution to journal › Article
- 2016
-
Mark
Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
(
- Contribution to journal › Article
-
Mark
The impact of the fourth edition of the WHO classification of lung tumours on histological classification of resected pulmonary NSCCs.
(
- Contribution to journal › Article
-
Mark
A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort
(
- Contribution to journal › Article